Skip to main Content


Executive Leadership

Richard Ferrari Executive Chairman

Richard Ferrari is a Tenon Founder, Director, and Executive Chairman of the Company. Since 2000, Mr. Ferrari has been Managing Director of Denovo Ventures, specializing in Medical Devices and Biotechnology. Mr. Ferrari previously served as CEO and Chairman of the Board of Directors of PQ Bypass, which culminated in a successful acquisition by Endologix. Mr. Ferrari is Executive Chairman of the Board for Medlumics, S.L.; Vice Chairman of the Board for ABS Interventional; Executive Chairman of the Board for Heart Beam Inc.; a board member of Biomodex Corporation, Retriever Medical Inc., RMx Medical, Hawthorne Effect, Inc., and Hands of Hope; board member and co-founder of TransAortic (acquired by Medtronic); Executive Chairman of Sentreheart (acquired by Atricure), board member of Spinal Modualtion (acquired by St Jude). Mr. Ferrari has raised over $1Billion for the companies he has been involved with and has been a key member of M&A teams, achieving over $2Billion in acquisitions.  Mr. Ferrari is a mentor and advisor to CEOs and start-up companies on strategy and building organizations dedicated to delivering excellence. Mr. Ferrari is the creator of Excellence by Choice, a series of lectures and presentations to help early-stage companies perform at the highest level of execution. Mr. Ferrari received a Bachelor’s Degree in Education from Ashland University and an MBA from University of South Florida.

Steven M. Foster Chief Executive Officer & President

Steven M. Foster serves as Chief Executive Officer & President and is also a Director of the Company. Mr. Foster has over 30 years of marketing, sales, operations, and general management experience in the medical device industry. Most recently, Mr. Foster was the principal with CTB Advisors, LLC, providing medical device organizations with consultative assistance on commercialization-focused projects. Clients included NuVasive (NUVA), SafeOp Surgical, and ATEC Spine (ATEC).

Mr. Foster was Global Commercialization President of Safe Orthopaedics SAS; VP/GM of Medtronic Spine’s Western Europe operations, and held a progressive succession of sales, marketing, and general management roles in the Danek Group Inc., Sofamor Danek, Medtronic Spine & Biologics organization. Mr. Foster started his career in a variety of operational roles with Stryker Endoscopy (SYK). Mr. Foster received a Bachelor of Science, Business Administration with a concentration in Marketing and Management, and Logistics from Central Michigan University.

Richard Ginn Chief Technology Officer

Richard Ginn is a founder of Tenon Medical and is the Chief Technology Officer and a Director of the company, with a focus on intellectual property and product development. Mr. Ginn has traveled globally to train physicians and participate in FIH trials. He is a named inventor on more than 300 patents for medical devices. Mr. Ginn has helped raise more than $100 million in venture capital. In 2013, Mr. Ginn founded TransAortic Medical, an embolic protection device company, and is the President, CEO, and a Director. At TransAortic, Mr. Ginn managed all corporate operations, raised capital to support company needs; managed the acquisition of technology by a strategic partner; managed all Intellectual Property; and set up European distribution for a CE Marked device. Mr. Ginn is the founder of Promed, a large hole femoral closure device company, where he was the CEO, President and a Director.

Steven Van Dick  Chief Financial Officer & Executive Vice President, Finance & Administration

Steven Van Dick is Tenon Medical’s Chief Financial Officer & Executive Vice President, Finance and Administration. Mr. Van Dick is a strategic financial and accounting executive and is well respected in the medical device startup community. He has played a key role on Executive Leadership Teams, successfully completing three separate IPOs and four merger/integrations. Most recently, Mr. Van Dick held consulting roles with various medical device companies, was Chief Financial Officer for Benvenue Medical Inc., a spinal fusion company, and Vice President, Finance Administration & CFO for Spiracur Inc., a disposable/portable negative pressure wound therapy company. Mr. Van Dick received a Bachelor of Science, Business Administration with a concentration in Accounting from San Jose University and an MBA from Santa Clara University.